{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:27:19Z","timestamp":1790681239495,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":388,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jacc.2022.10.030","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T14:05:37Z","timestamp":1673877937000},"page":"224-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2\u00a0Infection"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2355-4589","authenticated-orcid":false,"given":"Eliano P.","family":"Navarese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Podhajski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Gurbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudyna","family":"Grzelakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Ruscio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya","family":"Tantry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Magielski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldona","family":"Kubica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Niezgoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Adamski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Junik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Przybylski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pilaczy\u0144ska-Cemel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Rupji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Specchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Pinkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gajda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana A.","family":"Gorog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicita","family":"Andreotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Kubica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2022.10.030_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-05371-2","article-title":"Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis","volume":"20","author":"Xie","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jacc.2022.10.030_bib2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.40071","article-title":"Cytokine storm syndrome: looking toward the precision medicine era","volume":"69","author":"Behrens","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jacc.2022.10.030_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s11739-021-02742-8","article-title":"Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI)","volume":"16","author":"Corradini","year":"2021","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jacc.2022.10.030_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","article-title":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy","volume":"180","author":"Grasselli","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2022.10.030_bib5","first-page":"200","article-title":"Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy","volume":"22","author":"Zangrillo","year":"2020","journal-title":"Crit Care Resusc"},{"key":"10.1016\/j.jacc.2022.10.030_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacc.2022.10.030_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol J"},{"key":"10.1016\/j.jacc.2022.10.030_bib8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12879-021-05945-8","article-title":"Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak","volume":"21","author":"Sabaka","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jacc.2022.10.030_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41569-021-00665-7","article-title":"Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the International COVID-19 Thrombosis Biomarkers Colloquium","volume":"19","author":"Gorog","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2022.10.030_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/ehjcvp\/pvv045","article-title":"From proprotein convertase subtilisin\/kexin type 9 to its inhibition: state-of-the-art and clinical implications","volume":"2","author":"Navarese","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2022.10.030_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/ehjcvp\/pvz022","article-title":"PCSK9 and inflammation: a review of experimental and clinical evidence","volume":"5","author":"Momtazi-Borojeni","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2022.10.030_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008782","article-title":"PCSK9 is a critical regulator of the innate immune response and septic shock outcome","volume":"6","author":"Walley","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacc.2022.10.030_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ebiom.2018.11.032","article-title":"Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors","volume":"38","author":"Genga","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jacc.2022.10.030_bib14","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/s41598-018-20425-x","article-title":"PCSK9 induces a pro-inflammatory response in macrophages","volume":"8","author":"Ricci","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2022.10.030_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4149\/gpb_2019057","article-title":"PCSK9 promotes the secretion of pro-inflammatory cytokines by macrophages to aggravate H\/R-induced cardiomyocyte injury via activating NF-\u03baB signalling","volume":"39","author":"Yang","year":"2020","journal-title":"Gen Physiol Biophys"},{"key":"10.1016\/j.jacc.2022.10.030_bib16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/SHK.0000000000000682","article-title":"Differential expression of PCSK9 modulates infection, inflammation, and coagulation in a murine model of sepsis","volume":"46","author":"Dwivedi","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.jacc.2022.10.030_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47242-0","article-title":"Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE\u22173Leiden.CETP mice","volume":"9","author":"Schuster","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2022.10.030_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk\u2014the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.10.030_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5603\/CJ.a2021.0148","article-title":"IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: rationale and protocol of the IMPACT-SIRIO 5 study","volume":"29","author":"Kubica","year":"2022","journal-title":"Cardiol J"},{"key":"10.1016\/j.jacc.2022.10.030_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4329\/wjr.v13.i10.327","article-title":"COVID-19 pneumonia: a review of typical radiological characteristics","volume":"13","author":"Churruca","year":"2021","journal-title":"World J Radiol"},{"key":"10.1016\/j.jacc.2022.10.030_bib22","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.jacc.2021.08.021","article-title":"Investigating lipid-modulating agents for prevention or treatment of COVID-19: JACC State-of-the-Art Review","volume":"78","author":"Talasaz","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.10.030_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jclinepi.2011.07.011","article-title":"The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency","volume":"65","author":"Sim","year":"2012","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jacc.2022.10.030_bib24","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/sim.4780141709","article-title":"On the use of a pilot sample for sample size determination","volume":"14","author":"Browne","year":"1995","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2022.10.030_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/pst.185","article-title":"Sample size of 12 per group rule of thumb for a pilot study","volume":"4","author":"Julious","year":"2005","journal-title":"Pharmaceut Stat"},{"key":"10.1016\/j.jacc.2022.10.030_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00541-2020","article-title":"Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit","volume":"7","author":"Vaschetto","year":"2021","journal-title":"ERJ Open Research"},{"key":"10.1016\/j.jacc.2022.10.030_bib27","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/jmv.25948","article-title":"Elevated interleukin-6 and severe COVID-19: a meta-analysis","volume":"92","author":"Aziz","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jacc.2022.10.030_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaci.2020.07.009","article-title":"IL-6-based mortality risk model for hospitalized patients with COVID-19","volume":"146","author":"Laguna-Goya","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jacc.2022.10.030_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/clinchem\/45.1.7","article-title":"New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases","volume":"45","author":"Chen","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2022.10.030_bib30","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe Covid-19 pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.10.030_bib31","doi-asserted-by":"crossref","unstructured":"Huang L, Li Y, Cheng Z, Lv Z, Luo S, Xia Y. PCSK9 promotes endothelial dysfunction during sepsis via the TLR4\/MyD88\/NF-\u03baB and NLRP3 pathways. Inflammation. Published online August 5, 2022. https:\/\/doi.org\/10.1007\/s10753-022-01715-z","DOI":"10.21203\/rs.3.rs-1325215\/v1"},{"key":"10.1016\/j.jacc.2022.10.030_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacl.2020.04.008","article-title":"Hypolipidemia is associated with the severity of COVID-19","volume":"14","author":"Wei","year":"2020","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2022.10.030_bib33","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1186\/s12879-022-07570-5","article-title":"Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial)","volume":"22","author":"Ghati","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jacc.2022.10.030_bib34","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/s41591-021-01500-9","article-title":"Calming the cytokine storm in COVID-19","volume":"27","author":"Cron","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2022.10.030_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722074083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722074083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:55:00Z","timestamp":1760018100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109722074083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0735109722074083"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2022.10.030","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742506769.793598118","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2\u00a0Infection","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2022.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}